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Strongyloides stercoralis, the chief causative agent of human strongyloidiasis, is a nema-
tode globally distributed but mainly endemic in tropical and subtropical regions. Chronic
infection is often clinically asymptomatic but it can result in severe hyperinfection syndrome
or disseminated strongyloidiasis in immunocompromised patients. There is a great diversity
of techniques used in diagnosing the disease, but definitive diagnosis is accomplished by
parasitological examination of stool samples for morphological identification of parasite.
Until now, no molecular method has been tested in urine samples as an alternative to stool
samples for diagnosing strongyloidiasis. This study aimed to evaluate the use of a new
molecular LAMP assay in a well-established Wistar rat experimental infection model using
both stool and, for the first time, urine samples. The LAMP assay was also clinically evalu-
ated in patients´ stool samples.
Methodology/Principal Findings
Stool and urine samples were obtained daily during a 28-day period from rats infected sub-
cutaneously with different infective third-stage larvae doses of S. venezuelensis. The
dynamics of parasite infection was determined by daily counting the number of eggs per
gram of feces from day 1 to 28 post-infection. A set of primers for LAMP assay based on a
DNA partial sequence in the 18S rRNA gene from S. venezuelensis was designed. The set
up LAMP assay (namely, Strong-LAMP) allowed the sensitive detection of S. venezuelensis
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DNA in both stool and urine samples obtained from each infection group of rats and was
also effective in S. stercoralis DNA amplification in patients´ stool samples with previously
confirmed strongyloidiasis by parasitological and real-time PCR tests.
Conclusions/Significance
Our Strong-LAMP assay is an useful molecular tool in research of a strongyloidiasis experi-
mental infection model in both stool and urine samples. After further validation, the Strong-
LAMP could also be potentially applied for effective diagnosis of strongyloidiasis in a clinical
setting.
Author Summary
Human strongyloidiasis, a soil-transmitted infection mainly caused by Strongyloides ster-
coralis, is one of the most neglected among the so-called neglected tropical diseases
(NTDs). The difficult diagnosis lead to an underreporting of infection rates. Strongyloidia-
sis can easily be misdiagnosed because many infections remain asymptomatic and the lack
of sensitivity of the conventional fecal-based techniques for morphologically identification
of infective larvae in feces. Although serologic tests are useful, a limitation in standardiza-
tion to avoid cross-reactions still remains. There is an urgent need to improve more
sensitive and specific diagnostic tests, particularly in immunocompromised patients or
candidates to immunosuppressive treatments. Several molecular approaches for Strongy-
loides spp. DNA detection have already been assayed, but they have a very limited use in
routine diagnostic, particularly in endemic areas. In addition, all molecular approaches for
Strongyloides spp. DNA detection have always been mainly assayed for stool samples and
no other more advantageous biological samples, such as urine, have been investigated for
molecular purposes. In this study we have developed, for the first time, a molecular assay
using LAMP methodology as a simple, sensible and robust method for the detection of S.
venezuelensis DNA in a well-established Wistar rats experimental infection in both stool
and urine samples. The LAMP assay was also successfully evaluated in patients´ stool sam-
ples. Our LAMP assay (Strong-LAMP) is an useful molecular tool in a strongyloidiasis
experimental infection model and could be a potential field-friendly diagnostic test in a
clinical setting, following further validation.
Introduction
Strongyloidiasis, a soil-transmitted helminth human infection, is considered by World Health
Organization (WHO) as a neglected condition affecting an estimated 30–100 million people
worldwide [1]. The accuracy of these estimates remains actually uncertain due to lack of effi-
cient guidelines for screening the population in epidemiological surveys [2, 3]. At least, two
species of nematodes of the genus Strongyloides, namely Strongyloides stercoralis (the most
common human pathogen species) and S. fuelleborni, are known to infect humans causing
strongyloidiasis [4, 5, 6]. Human infection is primarily acquired by the filariform larvae (the
infective third-stage larvae, iL3) penetrating the skin or mucous membranes through unpro-
tected contact with contaminated soil [7]. S. stercoralis biology is complex involving two sepa-
rate life cycles, the free-living heterogonic cycle and a parasitic cycle [8, 9]. The exceptional
ability of this parasite to replicate in the human host permits ongoing cycles of autoinfection
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thus resulting in a chronic strongyloidiasis that can therefore persist for several decades with-
out further exposure to a new exogenous infection [6]. Inmunocompetent patients with
uncomplicated strongyloidiasis usually develop an asymptomatic, mildly symptomatic or
chronic infection, which are typically associated with low intestinal worm burdens and inter-
mittent larval excretion [10, 2]. However, a deregulation of the host´s immune response during
the latent infection may lead in an uncontrolled multiplication of the parasites (hyperinfection
syndrome) which can be life-threatening [6, 2, 10, 11, 7] with mortality rates of up 87% [12,
13]. Thus, detecting latent cases of S. stercoralis is crucial to decrease morbidity and mortality
of the infection.
The diagnosis of strongyloidiasis is suspected when clinical signs and symptoms, eosino-
philia or serologic findings are observed [14, 6], but definitive diagnosis is accomplished by
parasitological examination of stool samples allowing the morphological identification of S.
stercoralis, including direct smear in saline, the spontaneous sedimentation method [15], cen-
trifugation [16], the Baermann´s technique [17], the agar plate culture [18] and the Harada-
Mori´s filter paper culture method [19]. These methods have classically low sensitivity because
of the low and irregular load of larvae in the feces [6]; the collection of a larger number of stool
samples on alternate days instead of a single one and the combination of several diagnostic
methods may increase the sensitivity [20]. On the other hand, several immunological methods
have been described for diagnosing strongyloidiasis showing a high sensitivity when compared
with parasitological methods but a limitation in the standardization of more specific serological
tests in order to avoid the possibility of cross-reaction with other helminths still remains [21,
22]. Several DNA-based techniques (i.e. single-PCR, nested-PCR, PCR-RFLP, real-time PCR)
have provided useful alternatives not only for identification of Strongyloides species [23, 24]
but also for S. stercoralis DNA detection in feces with high accuracy in the diagnosis of strongy-
loidiasis [22, 25, 26, 27]. Nevertheless, such molecular methods have a very limited use in
routine diagnostic, particularly under field conditions in endemic areas requiring special equip-
ment manipulated by trained personnel. Thus, the development of new, simple, applicable and
cost-effective alternative molecular assays is necessary to diagnose human strongyloidiasis,
mainly in those immunocompromised individuals in which the infection can be fatal.
At present, there is a nucleic acid amplification method named loop-mediated isothermal
amplification (LAMP) [28]. Compared to PCR, the simplicity of the LAMP method makes it
suitable for field testing in developing countries [29, 30], and many LAMP reactions have
already been developed for molecular detection and diagnostics of infectious diseases, includ-
ing parasitic diseases [31]. In this sense, a first LAMP assay for the detection of S. stercoralis in
feces has been recently developed and preliminary evaluated with human stool samples [32].
To date, all new successfully approaches for molecular methods to be used for Strongyloides
spp. DNA detection have been focused in analyzing mainly stool samples and no other type of
sample, such as urine, has been considered for the detection of parasite DNA. Urine is a biolog-
ical sample that would have a number of advantages in diagnosis of strongyloidiasis over the
stool samples since it has less inconvenience to obtain from patients as well as it is easier in
handling and storing. It has been demonstrated that small amounts of cell-free circulating
DNA are able to pass the kidney barrier and end up in urine [33, 34, 35]; this circulating
DNA from the bloodstream that passes into the urine can be isolated and used in diagnostic
applications.
This study aimed to assess the diagnostic utility of a new designed LAMP assay in an active
experimental rodent strongyloidiasis in parallel with parasitological method by direct fecal
examination. We used as a source for Strongyloides spp. DNA detection both stool and, for the
first time, urine samples from rats experimentally infected with different doses of S. venezuelen-
sis iL3. The LAMP developed in this work (namely, Strong-LAMP) was shown to be sensitive
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and specific in detecting Strongyloides spp. DNA. The potential diagnostic applicability of the
Strong-LAMP could be also demonstrated on a number of human clinical stool samples with
previously parasitological and real-time PCR confirmed strongiloidiasis.
Methods
Ethics statement
The study protocol was approved by the institutional research commission of the University of
Salamanca. Ethical approval was obtained from the Ethics Committee of the University of Sala-
manca (protocol approval number 48531), which approved the animal protocol. Animal proce-
dures in this study complied with the Spanish (Real Decreto RD53/2013) and the European
Union (European Directive 2010/63/EU) guidelines on animal experimentation for the protec-
tion and humane use of laboratory animals and were conducted at the accredited Animal
Experimentation Facility of the University of Salamanca (Register number: PAE/SA/001).
The human stool samples used in this study were obtained as part of public health diagnostic
activities at Severo Ochoa and Gregorio Marañón Hospitals, Madrid, Spain. A standardized
epidemiological questionnaire and clinical information were obtained from each participant
included in the study. Participants were given detailed explanations about the aims, procedures
and possible benefit of the study. Written informed consent was obtained from all subjects and
samples were coded and treated anonymously. The study received the approval of the Commit-
tee of Research Ethics and Animal Welfare from the Instituto de Salud Carlos III (PI number:
CEI PI06_2012-v2).
Animals
Twelve six-week-old male Wistar rats weighing 150–175 g (Charles River Laboratories, Barce-
lona, Spain) were used in our study as the source for stool and urine samples. Animals were
housed at the accredited Animal Experimentation Facility of the University of Salamanca in
individual metabolic polycarbonate cages and placed in humidity and temperature controlled
environment with a 12 hour photoperiod and received sterilized food and water ad libitum.
Animals were monitored regularly by qualified members in animal welfare at the Animal
Experimentation Facility of the University of Salamanca.
Strongyloides venezuelensis experimental infection
Strongyloides venezuelensis used in this study was obtained from a strain originally used in the
Department of Parasitology, University of Minas Gerais, Belo Horizonte, Brazil. This strain has
been maintained by serial passages in laboratory rats routinely infected in the Laboratory of Par-
asitic and Molecular Immunology, CIETUS, University of Salamanca. Feces from infected rats
were cultured using vermiculite mixed with distilled water at 28°C for 3–7 days and infective
third-stage larvae (iL3) which came out of the feces were then collected and concentrated by
using the Baermann extraction method as described elsewhere [36]. Recovered larvae were
washed in phosphate-buffered saline (PBS) and their viability was checked using a light micro-
scope prior to infection. The number of viable iL3 was determined and the animals were after-
wards infected subcutaneously with different iL3 doses of S. venezuelensis to ensure a potential
range of low, middle and high fecal egg production during the development of infection [37], as
follows: group one (n = 3; each rat infected with 40 iL3), group 2 (n = 3; each rat infected with
400 iL3), group 3 (n = 3; each rat infected with 4,000 iL3) and group 4 (n = 3; non infected, as
control group). During the 28-day infection, the animals were housed individually in metabolic
cages, thus allowing separate collection of urine and feces from rodents and also to eliminate the
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possibility of rats re-infecting themselves from fecal sources during the experimental period.
Infected rats were euthanatized in a CO2 gas chamber 29 days after the infection.
Rat samples and monitoring S. venezuelensis infection
Rat stool samples. Feces were taken daily from all rats housed individually in the meta-
bolic cages throughout the 28-day infection. The three stool samples taken daily from each
group of three rats (infected and non-infected) were pooled and the resulting mix was treated
as a single sample that was subsequently divided into two portions: one (0.7–1 g, approxi-
mately) was freeze-dried stored at -20°C to be used afterward for DNA extraction and another
was kept at ambient temperature by adding 3% formalin to the remaining feces (3–5 mL,
depending on the volume of fecal sample) to preserve parasite eggs for later counting.
The dynamics of S. venezuelensis infection was determined by daily counting the number of
eggs per gram of feces (EPG) by a modified McMaster technique [38] from day 1 post-infection
(p.i.) until day 28 p.i.. The EPG counting was performed by triplicate in the daily pool of stool
samples preserved in formalin obtained from each infected group of animals as mentioned
above. Results obtained were expressed as mean±SE.
Rat urine samples. Urine samples were also individually taken daily from all animals
throughout the 28-day infection. The three urine samples taken daily from each group of three
rats (infected and non-infected) were also pooled and the resulting mix was treated as a single
sample to minimize the number of subsequent reactions. Each daily pool was afterward divided
into two aliquots: one aliquot (1 mL) was immediately used for DNA extraction for molecular
analyses and another (a variable remaining volume) was stored at -20°C.
Human stool samples and parasitological tests
Human stool samples (n = 12) were obtained from outpatients (including Spanish nationals,
immigrants, tourists and aid workers) attending Severo Ochoa and Gregorio Marañón Hospi-
tals in Madrid, Spain, during June 2010 to June 2012 as a part of a collaborative research study
on human strongyloidiasis. Those patients showed significant levels of IgE, eosinophilia or
other symptoms suggestive of disease. Stool samples were examined after arrival by qualified
laboratory technicians. Eleven of these 12 stool samples (nos. 030, 140, 231, 232, 338, 339, 069,
259, 331, 468 and 126) were subjected to different parasitological methods as screening tests
for strongyloidiasis, including microscopic examination (MOE) for the presence of rabditiform
larvae in direct fecal smears, agar plate culture (APC) or Harada-Mori´s filter paper culture
method (HMM). Unfortunately, for one sample (no. 496) was not possible to perform any of
the parasitological methods. Strongyloidiasis was confirmed in 7/11 stool samples by one or
more parasitological tests applied. Four samples (nos. 259, 331, 468 and 126) were found to be
negative; however, in two of these negative samples (nos. 468 and 126) eggs from Taenia sagi-
nata and "hookworm", respectively, could be observed upon microscopic inspection. All
patients´ samples were obtained before treatment with ivermectin. Thereafter, patients´ stool
samples were sent to the Instituto de Salud Carlos III (ISCIII), Madrid, Spain, for further DNA
extraction and molecular analyses by real-time PCR (RT-PCR) as described below. Table 1
shows the patients´ stool sample numbers, the parasitological tests applied at Hospitals as well
as results obtained in parasitological and molecular tests performed.
DNA extraction for molecular analyses
Parasites DNA samples. S. venezuelensis genomic DNA was extracted from iL3 using the
Dneasy Blood & Tissue kit (QIAGEN, Hilden, Germany) following the manufacturers´
instructions. DNA was eluted with 100 μL AE buffer and the concentration of S. venezuelensis
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DNA iL3 was measured three times by spectrophotometry using a Nanodrop ND-100 spectro-
photometer (Nanodrop Technologies) to obtain an average concentration and then diluted
with ultrapure water to a final concentration of 5 ng/μL. Subsequently, serial 10-fold dilutions
from S. venezuelensis DNA iL3 thus obtained were also prepared with ultrapure water ranging
from 1x10-1 (0.5 ng/μL) to 1x10-10 (0.0005 fg/μL) and stored at -20°C until use. DNA thus pre-
pared was used as a positive control in all PCR and LAMP reactions as well as for assessing sen-
sitivity of both assays.
Additionally, to determine the specificity of both PCR and LAMP assays to amplify only S.
venezuelensisDNA, a total of 22 DNA samples from several helminths and protozoa were used as
heterogeneous control samples, including Schistosoma mansoni, S. intercalatum, S. haematobium,
S. japonicum, S. bovis, Fasciola hepatica, Loa loa, Brugia pahangi,Dicrocoelium dendriticum,
Calicophoron daubneyi,Hymenolepis diminuta, Taenia taeniformis, Anisakis simplex, Trichinella
spiralis, Echinostoma caproni, Echinococcus granulosus, Cryptosporidium parvum, Giardia intesti-
nalis, Entamoeba histolytica, Plasmodiummalariae, P. ovale and P. vivax. Concentration of all
DNA samples was measured by the same method as described for S. venezuelensis iL3 DNA and
then also diluted with ultrapure water to a final concentration of 0.5 ng/μL. In order to look for
protein contaminations a common purity check by measuring the A260/A280 ratio was made for
all samples. All these DNA samples were kept at -20°C until use in molecular assays.
DNA from rat stool samples. Approximately 200 mg of frozen stool samples from each
daily pool obtained from each group of animals were used for DNA extraction using the
NucleoSpin Tissue Kit (Macherey-Nagel, GmbH & Co., Germany)- according to the modified
protocol for DNA extraction from stool- following the manufacturers´ instructions. All DNA
samples obtained from feces from non-infected rats (group 4) were pooled and the resulting
mix was treated as a single negative control sample to minimize the number of subsequent
molecular reactions. Purified DNA samples were stored at -20°C until use.
DNA from rat urine samples. The DNA of 1mL of daily pooled urine samples from each
group of rats was extracted using the i-genomic Urine DNA Extraction Mini Kit (Intron Bio-
technology) following the manufacturers´ instructions. Once extracted, the purified DNA of
urine samples was stored at -20°C until use in molecular assays.
DNA from patients´ stool samples. Prior to DNA extraction, 1 g of each stool sample
was resuspended in 8 mL of saline solution and concentrated using Bioparapred-Midi columns
(Leti Diagnostics, Barcelona, Spain). Then, the supernatants were discarded and 200 mg of the
Table 1. Patients´ stool sample numbers included in this study and parasitological andmolecular tests applied for Strongyloides stercoralis
detection.
Patients´ stool samples
030 140 231 232 338 339 496a 069 259 331 468b 126c
Tests
APC + + + + + - - - -
HMM + + - - - -
MOE + + + + + - - - -
RT-PCR + + + + + + + - - - - -
LAMP + + + + + + + + - - - -
APC, agar plate culture; HMM, Harada-Mori´s method; MOE, microscopic examination
´+´ and ´-´ represent positive and negative results, respectively.
ano parasitological method applied.
bpositive for Taenia saginata.
cpositive for hookworm.
doi:10.1371/journal.pntd.0004836.t001
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pellets obtained were used for total DNA extraction using the QIAmp DNA Stool Mini kit
(QIAGEN, Hilden, Germany) following the manufacturer´s instructions. Purified DNA sam-
ples were stored at -20°C until use in RT-PCR at ISCIII, Madrid, Spain, and afterwards in PCR
and LAMP assays at CIETUS, Salamanca, Spain.
Real-time PCR amplification
Patients´ stool samples included in this study were firstly tested by a RT-PCR optimized at
ISCIII, Madrid, Spain, as described by Saugar et al. [27]. Briefly, the RT-PCR was standardized
in laboratory settings using the specific primers Stro18S-1530F (50-GAATTCCAAGTAAACG
TAAGTCATTAGC-30) and Stro18S-1630R (50-TGCCTCTGGATATTGCTCAGTTC-30) to
amplified a 101 base pair (bp) region of S. stercoralis 18S rRNA (Gene Bank accession no.
AF279916.2) as previously described by Verweij et al. [25]. The amplification was performed
with a 25 μL reaction mix containing 5 μL of DNA extracted from stool samples, 1X Quantimix
Easy Master Mix (Biotools B&M Laboratories), 0.2 μM of each Stro18S-1530F and Stro18S-
1630R primer and 0.5 μL of 50X SYBR Green I (Invitrogen). The program consisted of an ini-
tial step of 15 min at 95°C followed by 50 cycles of 10 s at 95°C, 10 s at 60°C and 30 s at 72°C.
The reaction and fluorescence detection were performed on the Corbett Rotor-Gene 6000 real-
time PCR System (QIAGEN, Hilden, Germany) and The Rotor Gene 6000 Series software v.1.7
was used for data analysis. In each RT-PCR run both negative (DNA from uninfected stool
sample) and positive (DNA from stool samples artificially infected with different amounts of S.
venezuelensis iL3 DNA) controls were routinely included.
LAMP primers design
After searching on literature reports to identify potential sequences of DNA to be used in
detection of Strongyloides spp., a 329 nucleotide bp corresponding to a linear genomic DNA
partial sequence in the 18S rRNA gene from S. venezuelensis was selected and retrieved from
GenBank (Accession No. AJ417026.1) for the design of specific primers [39]. A BLASTN
search and alignment analysis [40] indicated that the sequence had 94–99% similarity with
other sequences reported for Strongyloides spp. and no regions of similarity between this
sequence and other sequences reported for possible human pathogens were detected. The 329
bp sequence selected was also tested in silico for similarity in the currently available genome
databases for S. stercoralis at NemBase4 (www.nematodes.org) and a 94% identity with a partial
sequence in contig SSC06134_1 annotated for the parasite was obtained. Forward and back-
ward outer primers (F3 and B3) and forward and backward inner primers (FIP: F1c-F2 and
BIP: B1c-B2, respectively) were designed using the online primer design utility, Primer
Explorer v.4 (Eiken Chemical Co., Ltd., Japan; http://primerexplorer.jp/e/). Several LAMP
primer sets were suggested by the software and further refinement in primer design was devel-
oped manually based on the criteria described in “A Guide to LAMP primer designing” (http://
primerexplorer.jp/e/v4_manual/index.html). LAMP primers sequences finally selected are
indicated in Table 2 and their positions relative to the 329 bp target sequence of S. venezuelensis
compared with the 94% similarly partial sequence of S. stercoralis in contig SSC06134_1 are
shown in Fig 1. All the primers were of HPLC grade (Thermo Fisher Scientific Inc., Madrid,
Spain); the lyophilized primers were resuspended in ultrapure water to a final concentration of
100 pmol/μL and stored at -20°C until use.
LAMP F3 and B3 primer specificity tested by PCR
The outer LAMP primer pair, designated F3 and B3 (Table 2), was firstly tested for S. venezue-
lensis specificity by a touchdown-PCR to verify whether the correct target was amplified. The
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PCR assay was conducted in 25 μL reaction mixture containing 2.5 μL of 10x buffer, 1.5 μL of
25 mmol/L MgCl2, 2.5 μL of 2.5 mmol/L dNTPs, 0.5 μL of 100 pmol/L F3 and B3, 2 U Taq-
polymerase and 2 μL (10 ng) of DNA template. Initial denaturation was conducted at 94°C for
1 min, followed by a touchdown program for 15 cycles with successive annealing temperature
decrements of 1.0°C (from 57°C to 52°C) every 2 cycles. The specificity of PCR was also tested
with a panel of 22 heterogeneous DNA samples from other parasites included in the study.
Fig 1. Design of LAMP primers for detection of Strongyloides venezuelensis. (A) Nucleotide sequence alignment of the 329 bp selected
sequence (AJ417026.1) for S. venezuelensis (Sv) and a partial sequence in contig SSC06134_1 for S. stercoralis (Ss). The sequences used for
LAMP primers are indicated by arrows. (B) Schematic representation of AJ417026.1 and SSC06134_1 sequences and the primers used in this
study. Construction of the inner primers FIP (F1c+F2) and BIP (B1c+B2) are shown. F1c and B1c are complementary to F1 and B1, respectively.
doi:10.1371/journal.pntd.0004836.g001
Table 2. Sequences of LAMP primers for the amplification of the linear genomic DNA partial sequence in the 18S rDNA from Strongyloides vene-
zuelensis (GenBank Accession No. AJ417026.1).
Primera Length (bp) Sequence (5´-3´)
F3 21 ACACGCTTTTTATACCACATT
B3 18 GTGGAGCCGTTTATCAGG
FIP (F1c+F2) 49 ACCAGATACACATACGGTATGTTTT-GGATTTGATGAAACCATTTTTTCG
BIP (B1c+B2) 43 ATCAACTTTCGATGGTAGGGTATTG-CCTATCCGGAGTCGAACC
a F3, forward outer primer; B3, reverse outer primer; FIP, forward inner primer (comprising F1c and F2 sequences); BIP, reverse inner primer (comprising
B1c and B2 sequences).
doi:10.1371/journal.pntd.0004836.t002
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Besides, the sensitivity of the PCR was also assayed to establish the detection limit of S. vene-
zuelensis DNA with 10-fold serial dilutions prepared as mentioned above.
Optimization of LAMP assay
We tried to evaluate the LAMP primer set designed by using different in house reaction mix-
tures each containing a different Bst polymerase (namely, Bst DNA polymerase Large Frag-
ment, Bst DNA polymerase 2.0 and Bst DNA polymerase 2.0 WarmStart; New England
Biolabs, UK) as well as varying concentration of betaine (Sigma, USA) and supplementary
MgSO4 (New England Biolabs, UK) to compare results in S. venezuelensis DNA amplification.
Thus, LAMP reactions mixtures (25 μL) contained 40 pmol of each FIP and BIP primers, 5
pmol of each F3 and B3 primers, 1.4 mM of each dNTP (Bioron), 1x ThermoPol Reaction
Buffer -20 mM Tris-HCl (pH 8.8), 10 mM KCl, 10 mM (NH4)2SO4, 2 mMMgSO4, 0.1% Triton
X-100; New England Biolabs, UK- (when using Bst Polymerase Large Fragment) or 1x Isother-
mal Amplification Buffer -20 mM Tris-HCl (pH 8.8), 50 mM KCl, 10 mM (NH4)2SO4, 2 mM
MgSO4, 0.1% Tween20; New England Biolabs, UK- (when using either Bst DNA polymerase
2.0 or Bst DNA polymerase 2.0 WarmStart), betaine (ranging 0.8, 1, 1.2, 1.4 or 1.6 M), supple-
mentary MgSO4 (ranging 2, 4, 6 or 8 mM) and 8 U of the tested Bst polymerase in each case
with 2 μL of template DNA.
All LAMP reactions mixtures were performed in 0.5-mL micro centrifuge tubes that were
incubated in a heating block (K Dry-Bath) at a range of temperatures (61, 63 and 65°C) for 60
min to optimize the reaction conditions and then heated at 80°C for 5–10 min to inactivate the
enzyme and thus to terminate the reaction. In each case, the optimal temperature was deter-
mined and used in the subsequent tests. As the LAMP reaction is highly sensitive, possible
DNA contamination and carry-over of amplified products were prevented by using sterile
tools at all times, performing each step of the analysis in separate work areas, minimizing
manipulation of the reaction tubes and even closing them with a plastic paraffin film. Template
DNA was replaced by ultrapure water as negative control in each LAMP reaction.
Detection of LAMP products
Amplified DNA in the LAMP reaction causes turbidity due to the accumulation of magnesium
pyrophosphate, a by-product of the reaction. Once the reaction was finished and following a
brief spin of the reaction tubes, the turbidity of reaction mixture was visually inspected by
naked eyes. The LAMP amplification results could also be visually inspected by adding 2 μL of
1:10 diluted 10,000X concentration SYBR Green I (Invitrogen) to the reaction tubes. To avoid
as much as possible the potential risk of cross-contamination with amplified products, all tubes
were briefly centrifuged and carefully opened before adding the fluorescent dye. Green fluores-
cence was clearly observed in successful LAMP reaction, whereas it remained original orange
in the negative reaction. The LAMP products (3–5 μL) were also monitored using 2% agarose
gel electrophoresis stained with ethidium bromide, visualized under UV light and then photo-
graphed using an ultraviolet image system (Gel documentation system, UVItec, UK).
Analytical specificity and limit of detection of the LAMP assay
The specificity of the LAMP assay to amplify only S. venezuelensis DNA was tested against 22
DNA samples obtained from other parasites used as controls as mentioned above. To deter-
mine the lower detection limit of the LAMP assay, genomic DNA from S. venezuelensis 10-fold
serially diluted as mentioned above was subjected to amplification in comparison with the PCR
using outer primers F3 and B3.
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Evaluation of the LAMP assay
To evaluate the ability of the LAMP assay designed to amplify S. venezuelensis DNA in real
samples, we used DNA extracted from the pooled feces and urine samples taken daily from
each experimentally infected group of rats with different iL3 doses. To check whether LAMP
assay designed was also able to amplify DNA from S. stercoralis in clinical samples, we used the
patients´ stool samples included in the study. In all amplification assays, positive (S. venezue-
lensisDNA) and negative (DNAmix from non-infected rats stool or urine samples or ultrapure
water) controls were always included.
Results
Monitoring of S. venezuelensis infection by counting eggs in rat stool
samples
In the three infected groups, parasite eggs were detected for the first time in feces on the 6th
day p.i. regardless of the initial infecting doses (Fig 2). The maximal fecal egg count was 3,921
EPG on day 10 p.i in group 1 (Fig 2A), 12,092 EPG on day 9 p.i. in group 2 (Fig 2B) and
116,016 EPG on day 8 p.i. in group 3 (Fig 2C).
Analytical specificity and limit of detection of PCR using outer primers
When a PCR verification reaction was performed using primers F3 and B3 to amplify S. vene-
zuelensis DNA a 215 bp PCR product was successful amplified; the minimum amount of DNA
detectable by PCR was 0.01 ng. When a panel of 22 DNA samples from other parasites were
subjected to this PCR assay, amplicons were never obtained (S1 Fig).
Setting up LAMP assay
Considering the most consistent color change by adding SYBR Green I into the tubes, the
intensity of the ladder-like pattern on agarose gel electrophoresis as well as reproducibility of
tests, the best amplification results were always obtained when the reaction mixtures contained
Bst DNA polymerase 2.0 or Bst DNA polymerase 2.0 WarmStart combined with 1 M of betaine
and supplementary 6 mM of MgSO4 and the reaction tubes were incubated at 63°C for 60 min.
We also obtained amplification results when using Bst polymerase LF in such conditions, but
the color change in reaction tubes as well as the intensity of the ladder-like pattern on agarose
were always less evident compared to that obtained when using the other two enzymes; addi-
tionally, we did not get a good reproducibility of amplification trials so we discarded to use Bst
polymerase LF in the following applications. When we evaluated the sensitivity of both LAMP
reaction mixtures containing Bst polymerase 2.0 and Bst polymerase 2.0 WarmStart, the limit
of detection in S. venezuelensisDNA amplification was 0.1 ng and 0.01 ng, respectively. As sen-
sitivity was tenfold higher when using Bst polymerase 2.0 WarmStart, the reaction mixture
containing this enzyme was used in assessing the specificity of the LAMP assay. Then, the
LAMP assay was positive only for S. venezuelensis and no positive DNA products were
observed when other parasites species were used as templates (S2 Fig). Thereby, the LAMP
reaction mixture containing Bst polymerase 2.0 WarmStart was set up as the most suitable to
analyze all the samples included in the study and thenceforth was namely Strong-LAMP.
In addition, all non-template controls were negative for each batch of LAMP reactions, thus
indicating that there was no cross contamination and that with the primers set used there was
no template free amplification [41, 42].
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Fig 2. Monitoring of Strongyloides venezuelensis infection by counting eggs in rats’ stool samples. Rats were
experimentally infected with different infective third-stage larvae (iL3) doses of S. venezuelensis. (A) Group 1: rats infected
with 40 iL3. (B) Group 2: rats infected with 400 iL3. (C) Group 3: rats infected with 4,000 iL3. X axis represent days post-
infection. Y axis represent number of eggs per gram of feces (EPG) and (mean±SE).
doi:10.1371/journal.pntd.0004836.g002
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Examination of rat stool samples by LAMP
We tested by LAMP each daily pool of stool samples obtained from each infection group of
animals during a 28-day period (Fig 3). To avoid possible cross-contamination LAMP assays
were performed into two batches of 14 samples each. When testing stool samples from infected
rats with 40 iL3 (group 1) we obtained LAMP positive results continuously from day 6 p.i.
-when parasite eggs were detected in feces for the first time- until the end of infection at day 28
(Fig 3A). When testing stool samples from infected rats with 400 iL3 (group 2) and 4,000 iL3
Fig 3. Examination of rats’ stool samples by Strong-LAMP assay. Analysis of each daily pool of stool samples obtained from each infection group
of rats during a 28-day period. (A) Group 1, infected with 40 iL3. (B) Group 2, infected with 400 iL3. (C) Group 3, infected with 4,000 iL3. Lanes M, 50 bp
DNA ladder (Molecular weight marker XIII, Roche); Lanes Sv, genomic DNA from S. venezuelensis (1 ng); lanes 1–28, pooled feces samples obtained
at days 1–28 post-infection; lanes N, negative controls (pooled feces from non-infected rats, group 4).
doi:10.1371/journal.pntd.0004836.g003
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(group 3) we obtained in both groups LAMP positive results continuously from day 5 p.i. -one
day before the onset of parasite eggs in feces- until the end of infection at day 28 (Fig 3B and
3C). Negative controls (pooled DNA samples from feces from non-infected rats; group 4) were
never amplified and in all LAMP positive reactions a green fluorescence was clearly visualized
under natural light.
Examination of rat urine samples by LAMP
LAMP assay was also performed in each daily pool of urine samples obtained from each infec-
tion group of animals during a 28-day period (Fig 4). The 28 urine samples obtained from each
Fig 4. Examination of rats’ urine samples by Strong-LAMP assay. Analysis of each daily pool of urine samples obtained from each infection
group of rats during a 28-day period. (A) Group 1, infected with 40 iL3. (B) Group 2, infected with 400 iL3. (C) Group 3, infected with 4,000 iL3.
Lanes M, 50 bp DNA ladder (Molecular weight marker XIII, Roche); Lanes Sv, genomic DNA from S. venezuelensis (1 ng); lanes 1–28, pooled
urine samples obtained at days 1–28 post-infection; lanes N, negative controls (pooled feces from non-infected rats, group 4).
doi:10.1371/journal.pntd.0004836.g004
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infection group were tested in two batches of 14 samples each. Analyses of urine samples from
rats infected with 40 iL3 (group 1) showed LAMP positive results on days 6, 11–14, 16–23 and
26 p.i. (Fig 4A). Analyses of urine samples from rats infected with 400 iL3 (group 2) showed
LAMP positive results on days 3, 7–8, 10–23 and 25 p.i. (Fig 4B). Finally, analyses of urine sam-
ples from rats infected with 4,000 iL3 (group 3) showed LAMP positive results on days 3, 6–7
and continuously from day 9 until the end of infection on day 28 (Fig 4C). Four urine samples
considered as positive results (including those obtained on day 19 from group 1, on day 20
from group 2 and on days 12 and 21 from group 3) did not show a color change to green fluo-
rescent as appreciable as other LAMP positive results, but a faint ladder-like pattern could be
observed on agarose gel electrophoresis. We obtained DNA amplification in pooled urine sam-
ple from group 1 on the 6th day (the same day that parasite eggs were detected in feces for
the first time), but regarding group 2 and group 3, we detected DNA amplification in pooled
urine sample on the 3rd day (two days before than onset of parasite eggs in feces). Curiously,
LAMP positive results were not obtained on those days that the maximal fecal egg count was
observed in each infection group (i.e., day 10 for group 1, day 9 for group 2 and day 8 for group
3, respectively).
Evaluation of LAMP on diagnosis of human strongyloidiasis
All patients´ stool samples were tested by RT-PCR and LAMP to compare results. The
RT-PCR resulted positive in 6/7 patients´ stool samples with confirmed strongyloidiasis by
parasitological tests previously applied. In addition, a positive result was obtained in a sample
to which none parasitological test could be performed; negative results were obtained in nega-
tive parasitological samples for S. stercoralis (Table 1). All patients´ stool samples with con-
firmed strongyloidiasis by parasitological tests could be detected by LAMP, including the
sample which resulted negative in previous RT-PCR analyses. In addition, as for RT-PCR, we
also obtained a positive result in the sample to which parasitological tests were not available.
Negative parasitological patients´ stool samples for strongyloidiasis resulted in a negative
LAMP amplification, including those positive samples for Taenia saginata and "hookworn",
respectively (Table 1; S3 Fig).
Discussion
There are many difficulties in correctly diagnosing strongyloidiasis because most patients are
asymptomatic and the lack of sensitivity and specificity of the commonly used parasitological
and serological diagnostic methods, respectively [43]. Several PCR-based molecular methods
offering high sensitivity and specificity have been recently proposed in diagnosing strongyloidi-
asis [25, 22, 26, 27]. A LAMP method could be an economic, simple and applicable alternative
to PCR-based methods in field conditions for diagnostic assays [44]. On the other hand, all
new PCR-based approaches for Strongyloides spp. DNA detection have been always mainly
assayed for stool samples from both experimentally infected animals and clinical stool samples
[45, 46, 22, 25, 26, 27] but no other biological samples, such as urine, have been investigated for
molecular diagnostic purposes. In our work, we used a S. venezuelensis rodent model in order
to test a new LAMP assay for diagnosing strongyloidiasis both in stool and, for the first time,
urine samples. We used an experimental infection with S. venezuelensis since this parasitic
nematode has been widely used as a tool and laboratory model for human and animal strongy-
loidiasis research [47, 48]. The use of a S. venezuelensis rodent model allowed us to collect well-
defined stool and urine samples that would otherwise have been very difficult to obtain from
human patients, including samples from recently acquired infections and samples with low
parasite load resembling to those likely obtained in chronic human infections. Additionally, a
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classical parasitological diagnostic method, such as direct faecal examination by counting EPG
was used for monitoring infection as well as to compare results in parallel with molecular
assays.
Results obtained by counting EPG showed a similar dynamics of S. venezuelensis infection
to that previously reported not only by this parasite or by S. ratti in Wistar rats [49] but also in
Lewis rats [46] and in male Sprague-Dawley rats [50].
To design specific primers for our LAMP assay, a 329 nucleotide bp from the 5´ end of a lin-
ear DNA partial sequence in the 18S ribosomal RNA gene from S. venezuelensis was selected
[39]. For Strongyloides species, 18S ribosomal RNA gene (rDNA) has been analyzed [51, 52, 39,
53]. It is considered that small subunit ribosomal RNA (SSU rDNA) sequences within Strongy-
loides species are all very similar making the resolution of their phylogeny problematic as many
branch lengths are inferred to be very short when distance and likelihood methods are applied
[39, 53]. Closer analysis of the SSU rDNA sequences from a number of Strongyloides species
have been shown to identify a putative molecular synapomorphy (comprising 8 to 10 nucleo-
tides) within the E9-2 stem-loop of the V2 variable region, thus allowing to distinguish two
clades within Strongyloides genus: one containing Strongyloides spp. ex snake, S. stercoralis and
S. fuelleborni (namely "stercoralis" clade, with a 10 nucleotides sequence: ATTTTATATT), and
another containing S. ratti, S. suis, S. venezuelensis, S. cebus, S. fuelleborni kelleyi and S. papillo-
sus (namely "cebus" clade, with a 8 nucleotides sequence: ATT—TTTTC) [39]. Among the set
of primers automatically generated when designing LAMP for specific amplification of S. vene-
zuelensis, the F2 primer was finally manually selected to be used since its sequence at 3´ end
-which location serve as the replication starting point after annealing- would allow not only a
specific annealing in the 8 nuleotides sequence of "cebus" clade but also, theoretically, in the 10
nucleotides sequence of "stercoralis" clade if present in samples. Thus, the LAMP assay may be
employed for simultaneous detection of several Strongyloides species. At present, only S. ster-
coralis and S. fuelleborni are known to cause infection in humans but infection with other spe-
cies might be possible. Besides, the designed LAMP can also be use in the S. venezuelensis
experimental infection rodent model.
After verifying the operation and specificity of PCR F3-B3, we attempted to establish the
most suitable reaction mixture for the set of primers operation in the LAMP assay. The limit of
detection of the LAMP assay resulted tenfold higher when Bst polymerase 2.0 WarmStart was
used in comparison with Bst polymerase 2.0 (corresponding to 0.01 ng vs. 0.1 ng, respectively).
It has been previously reported a number of advantages of Bst polymerase WarmStart version
compared to other commercially available versions, such as faster amplification [54], increased
stability at room temperature [55] and also greater sensitivity [56, 57]. We emphasize the
importance of setting up the best conditions and molecular components for primers set opera-
tion in a LAMP assay. When analyzing the stool samples, the Strong-LAMP resulted more sen-
sitive than microscopy, at least in moderate and high levels of infection. A similar result has
been also reported for RT-PCR in comparison to microscopy in detecting first-stage larvae of
S. ratti in a rodent model infected subcutaneously with 2,500 iL3 [58]. When analyzing the
urine samples daily collected, we obtained Strong-LAMP positive results during the course of
infection depending on infection dose.
In a work carried out by Marra et al. [46], in which the migration route of S. venezuelensis
was evaluated by PCR and histological analysis in Lewis rats infected subcutaneously with
4,000 iL3, it was noted that the appearance of larvae in alveoli was already clear at 48 h p.i.. It
was also observed that at 72 h p.i. all infected animals had larvae in the lungs and no larvae
were found in any other organs that were examined. It was at this time, at 72 h p.i., when we
obtained Strong-LAMP positive results in urine samples from groups 2 and 3, thus indicating
the possibility of detecting S. venezuelensis free circulating DNA as a consequence of destroying
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larvae passing through the lungs and ending up in urine. Also according to that study, at 120 h
p.i. larvae begin to disappear from the lungs and were found inserted in the small intestine vill-
osities at 48–72 h later. Interestingly, it is also at this time in our study (approximately on the
9th day p.i.) when urine samples from group 3 (infected with 4,000 iL3) resulted Strong-LAMP
positive every day until the end of infection.
In group 2 (400 iL3) a first positive result was also obtained by Strong-LAMP in the pool of
urine samples at 72 h p.i.; however, a time lag in the appearance of positive results until the end
of infection in comparison to group 3 (4,000 iL3) was detected, possibly related to the lower ini-
tial infective dose. Such time lag in the appearance of positive results was much more apparent
when testing urine samples from group 1; since group 1 was infected with the lowest infective
dose of larvae (40 iL3), a first positive result obtained on day 6 p.i. would suggest that parasites
reached the lungs later and consequently it would take longer to settle them in the small intes-
tine villosities.
Unexpectedly, we did not obtained Strong-LAMP positive results in urine samples on days
in which the maximal fecal egg count was observed in each infection group. The absence of
information on this event or similar in already published data does not allow us to compare
our results. We can only speculate on the possibility of some features related to the dynamics
of the biological cycle of the parasite.
The potential clinical applicability of the Strong-LAMP could be demonstrated on a number
of human clinical stool samples. We obtained positive results in those stool samples with both
parasitological demonstration and confirmed detection by RT-PCR of S. stercoralis. In addi-
tion, the analysis of one sample (no. 496) with no parasitological test applied but positive by
RT-PCR, resulted positive by Strong-LAMP. Moreover, another sample (no. 069) with parasi-
tological demonstration of S. stercoralis but negative by RT-PCR resulted also positive by
Strong-LAMP; however, considering the limited number of human samples tested it is difficult
at this time to suggest a potential greater sensitivity of LAMP assay than RT-PCR in detecting
S. stercoralis DNA in stool samples. Furthermore, confirmed negative stool samples for S. ster-
coralis both by parasitological and RT-PCR methods resulted negative by Strong-LAMP as
well, even those samples infected with T. saginata and hookworm, thus corroborating once
again the specificity of our designed LAMP assay for exclusively detection of Strongyloides spp.
DNA. Although specificity was also previously determined in silico by using a thoroughly
BLASTN search and alignment analysis in online databases and no cross-reaction of other
sequences reported for possible human pathogens were detected, it is important to note that,
considering the absence of a single gold standard for strongyloides diagnosis, and because
LAMP products cannot be routinely sequenced to confirm identity, other micro-organisms
that may be commonly found in stool samples (e.g. bacteria and fungi, such as Candida spp.)
should be investigated in order to further validate the LAMP assay for human diagnosis.
In this work, we report for the first time, on the development of a new LAMP assay (Strong-
LAMP) for sensitive detection of S. venezuelensis DNA in both stool and urine samples in a
well-established Wistar rats experimental infection model. In addition, this Strong-LAMP
assay can be also applied effectively for the detection of S. stercoralis DNA in patients´ stool
samples. Clearly, in terms of potential human diagnostic, this assay requires additional valida-
tion using a greater number of clinical stool samples.
The successfully amplification of Strongyloides spp. DNA in infected urine samples by
LAMP assay as well as the advantages that urine would have in collection, storage and process-
ing in comparison to patients´ stool samples, should make us consider the possibility of start-
ing to use urine specimens in diagnosing human strongyloidiasis.
However, it will be convenient to further consider the difference between the samples from
a S. venezuelensis rodent model in acute disease and chronic human S. stercoralis infections.
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Since urine is actually an unusual requested biological sample from patients to detect S. stercor-
alis, further studies using clinical urine samples for human diagnostics of strongyloidiasis are
strongly-(LAMP) recommended.
Supporting Information
S1 Checklist. Checkmarks for the STARD Checklist.
(PDF)
S1 Flow Diagram. A diagram showing experimental design and results.
(PDF)
S1 Fig. PCR verification, detection limit and specificity using outer primers F3 and B3. (A)
PCR verification of expected 215 bp target length amplicon. Lane M, 50 bp DNA ladder
(Molecular weight marker XIII, Roche); lanes Sv, S.venezuelensis DNA (1 ng); lanes N1 and
N2, negative controls (no DNA template). (B) Detection limit of PCR. Lane M, 50 bp DNA lad-
der (Molecular weight marker XIII, Roche); lane Sv: S. venezuelensis DNA (1 ng); lanes 10−1–
10−6: 10-fold serially dilutions of S. venezuelensisDNA; lane N, negative control (no DNA tem-
plate). (C) Specificity of PCR. Lane M, 50 bp DNA ladder (Molecular weight marker XIII,
Roche); lanes Sv, Sm, Sh, Sj, Si, Sb, Fh, Dd, Hd, Ec, Cd, Ll, Bp, As, Tt, Eg, Ts, Pm, Po, Pv, Eh,
Gi, S. venezuelensis, S. mansoni, S.mansoni, S. haematobium, S. japonicum, S. intercalatum, S.
bovis, Fasciola hepatica, Dicrocoelium dendriticum,Hymenolepis diminuta, Equinostoma
caproni, Calicophoron daubneyi, Loa loa, Brugia pahangi, Anisakis simplex, Taenia taeniformis,
Echinococcus granulosus, Trichinella spiralis, Plasmodium malariae, P. ovale, P. vivax, Ent-
amoeba histolytica, Giardia intestinalis DNA samples (1 ng/each), respectively; lane N, negative
control (no DNA template).
(TIF)
S2 Fig. Setting up LAMP assay. (A) LAMP amplification results obtained using different poly-
merases tested in a heating block by the addition of SYBR Green I (up) or by visualization on
agarose gel (down). Lane M, 50 bp DNA ladder (Molecular weight marker XIII, Roche); lanes
FL, 2.0, WS, Bst polymerase Large Fragment, Bst polymerase 2.0, Bst polymerase WarmStart,
respectively. Lane N: negative control (no DNA template). (B) Sensitivity assessment of LAMP
assay performed with Bst polymerase 2.0. (C) Sensitivity assesment of LAMP assay performed
with Bst polymerase WarmStart. For (B) and (C): lane M, 50 bp DNA ladder (Molecular weight
marker XIII, Roche); lanes Sv, genomic DNA from S. venezuelensis (1 ng); lanes 10−1–10−10:
10-fold serially dilutions; lane N: negative controls (no DNA template). (D) Specificity of the
LAMP assay for S. venezuelensis. A ladder of multiple bands of different sizes could be only
observed in S. venezuelensis DNA sample. Lane M, 50 bp DNA ladder (Molecular weight
marker XIII, Roche); lanes Sv, Sm, Sh, Sj, Si, Sb, Fh, Dd, Hd, Ec, Cd, Ll, Bp, As, Tt, Eg, Ts, Pm,
Po, Pv, Eh, Gi, S. venezuelensis, S.mansoni, S.mansoni, S. haematobium, S. japonicum, S. inter-
calatum, S. bovis, Fasciola hepatica, Dicrocoelium dendriticum,Hymenolepis diminuta, Equi-
nostoma caproni, Calicophoron daubneyi, Loa loa, Brugia pahangi, Anisakis simplex, Taenia
taeniformis, Echinococcus granulosus, Trichinella spiralis, Plasmodium malariae, P. ovale, P.
vivax, Entamoeba histolytica, Giardia intestinalis DNA samples (1 ng/each), respectively; lane
N, negative control (no DNA template).
(TIF)
S3 Fig. Examination of patients´ stool samples by Strong-LAMP. Analysis of patients´ stool
samples included in the study by Strong-LAMP. In all positive LAMP results a green fluores-
cence was clearly visualized under natural light (up) or by electrophoresis in agarose gel
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(down). Lane M, 50 bp DNA ladder (Molecular weight marker XIII, Roche); lane Sv, genomic
DNA from S. venezuelensis (1 ng); numbers 030, 140, 231, 232, 338, 339, 496, 069, 259, 331,
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